These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17168876)

  • 1. A double-blind controlled study of a nonhydroquinone bleaching cream in the treatment of melasma.
    Levy JL; Pons F; Agopian L; Besson R
    J Cosmet Dermatol; 2005 Dec; 4(4):272-6. PubMed ID: 17168876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of glycolic acid peels in the treatment of melasma.
    Hurley ME; Guevara IL; Gonzales RM; Pandya AG
    Arch Dermatol; 2002 Dec; 138(12):1578-82. PubMed ID: 12472345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
    Leenutaphong V; Nettakul A; Rattanasuwon P
    J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 10% zinc sulfate solution for treatment of melasma.
    Sharquie KE; Al-Mashhadani SA; Salman HA
    Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
    Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
    J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.
    Huh SY; Shin JW; Na JI; Huh CH; Youn SW; Park KC
    Ann Dermatol; 2010 Feb; 22(1):21-5. PubMed ID: 20548876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
    Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
    J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
    Mansouri P; Farshi S; Hashemi Z; Kasraee B
    Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
    Jang WS; Lee CK; Kim BJ; Kim MN
    Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.